PATENT CLAIM ANALYSIS

Application Number: 16075110
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "293000"]

Abstract:
The present application present application relates to a compound represented by Formula (III) or a pharmaceutically acceptable salt, solvent compound, active metabolite, crystal polymorph, ester, isomer, or prodrug thereof. The application further provides a pharmaceutical composition comprising the compound represented by Formula (III) and a use thereof for preparing a bromodomain inhibitor for preventing or treating various diseases, such as inflammation and cancer, related to the bromodomain.

Claim (Index 15):
The compound or a pharmaceutically acceptable salt, solvate, active metabolite, polymorph, ester, isomer or prodrug thereof according to  claim 9 , wherein R 3  is selected from the group consisting of hydrogen, halogen, C 1-6  alkyl and C 3-8  cycloalkyl; and preferably, R 3  is selected from the group consisting of hydrogen, halogen and C 1-6  alkyl.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.65306
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15305384', '14819541', '14072563', '14207868', '14846545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8408831202750655
- 35 USC 102 Novelty (BERT): 0.5303045535077271
- Combined Prediction Score: 0.8098252635983316
- Mean Citation Score: 362.686824
- Max Citation Score: 366.06772
- Similarity Product: 289.47547793944364

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test